ML15267A827

Shine SER Chapter 14

ML15267A827
Person / Time
Site:	SHINE Medical Technologies
Issue date:	10/08/2015
From:	Office of Nuclear Reactor Regulation
To:
Lynch S
Shared Package
ML15267A796	List: ML15267A802 ML15267A812 ML15267A813 ML15267A814 ML15267A815 ML15267A816 ML15267A817 ML15267A818 ML15267A819 ML15267A820 ML15267A822 ML15267A824 ML15267A825 ML15267A826 ML15267A827 ML15267A828
References
Download: ML15267A827 (7)

Text

Chapter 14 Technical Specifications iii CONTENTS 14.0 TECHNICAL SPECIFICATIONS ............................................................................... 14-1 14.1 Areas of Review ............................................................................................ 14-1 14.2 Summary of Application ............................................................................... 14-1 14.3 Regulatory Basis and Acceptance Criteria ................................................. 14-2 14.3.1 Applicable Regulatory Requirements ............................................... 14-2 14.3.2 Regulatory Guidance and Acceptance Criteria ................................ 14-3 14.4 Review Procedures, Technical Evaluation, and Evaluation Findings ....... 14-3 14.5 Summary and Conclusion ............................................................................ 14-5 Chapter 14 Technical Specifications iii CONTENTS 14.0 TECHNICAL SPECIFICATIONS ............................................................................... 14-1 14.1 Areas of Review ............................................................................................ 14-1 14.2 Summary of Application ............................................................................... 14-1 14.3 Regulatory Basis and Acceptance Criteria ................................................. 14-2 14.3.1 Applicable Regulatory Requirements ............................................... 14-2 14.3.2 Regulatory Guidance and Acceptance Criteria ................................ 14-3 14.4 Review Procedures, Technical Evaluation, and Evaluation Findings ....... 14-3 14.5 Summary and Conclusion ............................................................................ 14-5